Emergency Medicine Doctors in East Boston, MA Accepting Medicare

10 Emergency Medicine doctors found. Showing 1 - 10

Dennis A Silvers, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Jill D Teplensky, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Phillip M Falkoff, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Dr. Henry Peter Beauparlant Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Susan K Boreri, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Pamela H Guggina, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-561-7716

Margaret Oakland, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Yhu-hsiung Lee, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Seth N Schonwald, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-568-4780

Dr. Irving S. Danesh, M.D. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 10 Gove St, East Boston, MA 02128 Phone: 617-569-5800    Fax: 617-567-4780

News Archive

PharmAthene presents Protexia clinical trial results at PHEMCE conference

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.

U.S. District Court rules in favor of Alnylam in patent infringement case against Tekmira

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied Tekmira Pharmaceuticals Corporation's motion to dismiss certain claims and motion to disqualify Alnylam's counsel in an infringement suit filed in January 2012.

Study finds wide racial gap in access to cancer surgery after NY State Medicaid expansion

The 2001 New York State Medicaid expansion - what is considered a precursor to the Affordable Care - widened the racial disparity gap when it came to access to high-quality hospitals for cancer surgery, according to a new study from Georgetown University.

New strategy to identify differences between non-metastatic and highly metastatic breast cancer cells

Researchers at the University of California, San Diego have used a new strategy to identify differences between non-metastatic and highly metastatic breast cancer cells. The article by Valerie Montel et al., "Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model," appears in the May 2005 issue of The American Journal of Pathology and is accompanied by a commentary.

Study highlights need for early identification, treatment of PTSD in cancer survivors

A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued to live with PTSD years later.

Read more Medical News

› Verified 1 days ago